This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Sep;15(10):1052-4.

doi: 10.1016/S1470-2045(14)70332-8. Epub 2014 Aug 4.

New prostate cancer drugs: extending and improving life

Neeraj Agarwal¹, Tanya Dorff², Amir Goldkorn³

Affiliations

Affiliations

¹ University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
² University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
³ University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: agoldkor@med.usc.edu.

PMID: 25104108
DOI: 10.1016/S1470-2045(14)70332-8

Comment

New prostate cancer drugs: extending and improving life

Neeraj Agarwal et al. Lancet Oncol. 2014 Sep.

. 2014 Sep;15(10):1052-4.

doi: 10.1016/S1470-2045(14)70332-8. Epub 2014 Aug 4.

Authors

Neeraj Agarwal¹, Tanya Dorff², Amir Goldkorn³

Affiliations

¹ University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
² University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
³ University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: agoldkor@med.usc.edu.

PMID: 25104108
DOI: 10.1016/S1470-2045(14)70332-8

No abstract available

PubMed Disclaimer

Comment on

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.
Fizazi K, Scher HI, Miller K, Basch E, Sternberg CN, Cella D, Forer D, Hirmand M, de Bono JS. Fizazi K, et al. Lancet Oncol. 2014 Sep;15(10):1147-56. doi: 10.1016/S1470-2045(14)70303-1. Epub 2014 Aug 4. Lancet Oncol. 2014. PMID: 25104109 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information